Daptomycin
NDC 70594-066, daptomycin, injection, powder, lyophilized, for solution, from Xellia Pharmaceuticals USA LLC.
- Product NDC
- 70594-066
- Status
- Listed
- Labeler
- Xellia Pharmaceuticals USA LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217415
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70594-066 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPTOMYCIN350 mg/7mL
Pharmacologic classes
Lipopeptide Antibacterial [EPC]; Lipopeptides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70594-066-01 | 70594006601 | 1 VIAL, SINGLE-USE in 1 CARTON (70594-066-01) / 7 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5e1f739a-eb81-43d8-9a14-89f32b7e1ba1Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70594-066
Use it
Look up 70594-066 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70594-066 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70594-066. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.